World Athletics 2023 WA vs Kumari Rachna

In November 2023 the Athletics Integrity Unit (AIU), on behalf of World Athletics, reported an anti-doping violation against the Indian Athlete Kumari Rachna after her A and B samples - collected in September 2023 - tested positive for the prohibited substances Dehydrochlormethyltestosterone, Metandienone and Stanozolol.

Additionally in December 2023 the India National Anti-Doping Agency (INADA) reported an anti-doping rule violation against the Athlete when her sample - collected in November 2023 - tested positive for Clenbuterol. Thereupon this case was transferred by INADA to the AIU.

Following notification a provisional suspension was ordered by the AIU. Hereafter the Athlete failed to respond at all or to provide any information to the AIU.

The AIU establishes that this is the Athlete's second anti-doping rule violation as she had served a sanction of 4 years until 17 March 2019 for the presence of Metenolone in her sample. Furthermore the AIU determines that there are aggravating circumstances in this case since the Athlete had used multiple prohibited substances on multiple occasions.

Because the Athlete failed to respond in February 2024 the AIU finds that she is deemed to have waived her right for a hearing, admitted the anti-doping rule violations and accepted the consequences.

Therefore the AIU decides on 13 February 2024 to impose a 12 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 24 November 2023.

Original document

Parameters

Legal Source
Decisions International Federations
Date
13 February 2024
Original Source
World Athletics (WA)
Country
India
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Acceptance of sanction
Admission
Aggravating circumstances
Multiple violations
Period of ineligibility
Second violation
Waiver of "right to be heard"
Sport/IFs
Athletics (WA) - World Athletics
Other organisations
Athletics Integrity Unit (AIU)
India National Anti-Doping Agency (INADA)
Laboratories
Lausanne, Switzerland: Laboratoire Suisse d’Analyse du Dopage
Analytical aspects
Atypical Finding (ATF)
B sample analysis
Doping classes
S1. Anabolic Agents
Substances
Clenbuterol
Dehydrochlormethyltestosterone (4-chloro-17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
Metandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
Stanozolol
Document type
Pdf file
Date generated
19 February 2024
Date of last modification
22 April 2024
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin